Acetone

Acetone

SCHEMBL3134673

CC(C)=O.[Cl-].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Acetone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetone SCHEMBL28397327 0.88
Acetone SCHEMBL28917569 0.88
Acetone SCHEMBL9772143 0.88
Acetone SCHEMBL7644305 0.88
Acetone SCHEMBL6926852 0.88
Acetone SCHEMBL11069607 0.88
Acetone SCHEMBL8977992 0.88
Acetone SCHEMBL1616144 0.88
Acetone SCHEMBL6009832 0.88
Acetone SCHEMBL28846007 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105218663-B A kind of preparation method of I-type collagen 河北柯瑞生物医药有限公司 2019-02-01 CN disclosed
EP-3328950-A1 HYDROGEL, PRODUCTION, AND MEDICAL DEVICE COMPRISING AN ELECTRODE COATED THEREWITH Leonh. Lang (AT) 2018-06-06 EP disclosed
CN-106243076-A A kind of preparation method of light-sensitive coloring agent used for solar batteries 雷春生 2016-12-21 CN disclosed
CN-105218663-A A kind of preparation method of I-type collagen HEBEI KERY BIOTECH CO LTD 2016-01-06 CN disclosed
EP-1654288-B9 POLYSACCHARIDES DERIVATIVES WITH HIGH ANTITHROMBOTIC ACTIVITY IN PLASMA INALCO SPA (IT) 2010-06-23 EP disclosed
US-7687249-B2 Polysaccharide derivatives with high antithrombotic activity in plasma INALCO S.P.A. (IT) 2010-03-30 US disclosed
EP-1654288-B1 POLYSACCHARIDES DERIVATIVES WITH HIGH ANTITHROMBOTIC ACTIVITY IN PLASMA INALCO SPA (IT) 2010-02-17 EP disclosed
US-20070042993-A1 Polysaccharides derivatives with high antithrombotic activity in plasma INALCO S.P.A. (IT) 2007-02-22 US disclosed
EP-1654288-A1 POLYSACCHARIDES DERIVATIVES WITH HIGH ANTITHROMBOTIC ACTIVITY IN PLASMA Inalco S.p.A. (IT) 2006-05-10 EP disclosed
CN-1622836-A Scaffolds for tissue engineered hair ADERANS RES INST INC (US) 2005-06-01 CN disclosed
EP-1239840-B1 ANTIVIRAL MEDICATION ALZA CORP (US) 2005-04-06 EP disclosed
WO-2005014656-A1 POLYSACCHARIDES DERIVATIVES WITH HIGH ANTITHROMBOTIC ACTIVITY IN PLASMA INALCO S.P.A. (IT) 2005-02-17 WO disclosed
CN-1537935-A Culture of microorganisms �Ƚ�����ҩ���о���˾ 2004-10-20 CN disclosed
EP-1239840-A2 ANTIVIRAL MEDICATION Alza Corporation (US) 2002-09-18 EP disclosed
US-20020071863-A1 Antiviral medication DONG LIANG C (US) 2002-06-13 US disclosed
WO-2001041742-A2 ANTIVIRAL MEDICATION ALZA CORPORATION (US) 2001-06-14 WO disclosed